News about Global Pharma

Evoke Pharma Welcomes Greg Pyszczymuka to Board of Directors

Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth. He currently serves as Chief Commercial Officer at Aytu BioPharma.

Global Pharma | 25/02/2025 | By Aishwarya |  149

Kineticos Launches Kinvard Bio to Power Next-Gen Antibiotics

KAMRA I is dedicated to combating antimicrobial resistance (AMR) by investing in, creating, and supporting companies that are developing disruptive solutions to address this critical public health issue.

Global Pharma | 25/02/2025 | By Aishwarya |  220

Co-Diagnostics Pulls 510(k) Application for PCR COVID-19 Test

Co-Diagnostics, Inc. announced that, following a collaborative and informative dialogue with the Food and Drug Administration (FDA), the Company has withdrawn its 510(k) application to the FDA for its Co-Dx™ PCR COVID-19 Test on the PCR Pro™, in favor of submitting an enhanced version of the test for 510(k) clearance.

Global Pharma | 24/02/2025 | By Manvi |  317

Zydus Secures USFDA Approval for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg

Zydus Lifesciences Ltd. has received final USFDA approval to manufacture Ibuprofen and Famotidine tablets (800 mg/26.6 mg) at its Ahmedabad facility.

Global Pharma | 24/02/2025 | By Manvi |  295

Indegene Develops Generative AI Platform Cortex for Life Sciences Sector

This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain, making medical writing more effective and efficient, and accelerating Medical-Legal-Regulatory (MLR) reviews.

Global Pharma | 24/02/2025 | By Aishwarya |  781

Granules India Expands into Peptide Therapeutics with Acquisition of Senn Chemicals

Senn Chemicals AG brings advanced expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), along with an established customer base in pharmaceuticals, cosmetics, and theragnostic industries.

Global Pharma | 24/02/2025 | By Aishwarya |  839

MGI Tech to Advance Genomic Innovation in Oncological Health

The Oncoclínicas&Co has now another advanced technology for cancer diagnosis with the addition of the medium-throughput DNBSEQ-G400 genomic sequencer.

Global Pharma | 24/02/2025 | By Aishwarya |  173

Lupin Secures EIR from US FDA for its Somerset Manufacturing Facility

Lupin Ltd. has received the Establishment Inspection Report (EIR) from the US FDA for its Somerset, New Jersey facility.

Global Pharma | 21/02/2025 | By Manvi |  1283

Senores Pharmaceuticals Acquires ANDA for Roflumilast 250 mcg and 500 mcg Tablets from Breckenridge Pharmaceutical

Senores Pharmaceuticals Ltd., through its US subsidiary, has acquired the USFDA-approved ANDA for Roflumilast 250 mcg and 500 mcg tablets from Breckenridge Pharmaceutical, strengthening its presence in the chronic bronchitis therapy market.

Global Pharma | 21/02/2025 | By Manvi |  291

Rentschler Biopharma Appoints Patrick Meyer as Global Head of Business Development

Dr. Meyer has been with the Rentschler Biopharma team for over eight years, most recently serving as Global Head BD Sales and Alliance Management.

Global Pharma | 21/02/2025 | By Aishwarya |  719